MarketCap
Facebook
X
Telegram
Cardlytics Financial Ratios 2025-2011 | CDLX
Brief overview of Cardlytics's market valuation
This overview follows the five latest available observations from 2021 through 2025.
Market valuation is represented by P/S 0.2x (median 0.59x), P/B 0.6x (median 2.22x). Valuation is roughly 69.7% below five-year reference levels. The discount may reflect opportunity or higher perceived risk.
Capital efficiency is characterized by ROE 16%, ROA -36.4%, ROCE 15.6%. The business is not generating positive returns on invested resources. Valuation should be read cautiously until earnings recover.
Price, earnings and growth produce a PEG of 0.33x. A value below one indicates moderate pricing relative to expected growth.
The cash cycle lengthened by 14 days to 145.4 days. Operations require more funding.
What the ratios show
Cardlytics's valuation is lower, but weak quality metrics call for caution. Recovery in earnings and capital returns is the key catalyst.
Annual Financial Ratios Cardlytics
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-0.4 | -0.2 | -2.2 | -0.4 | -16.8 | -60.0 | -117.6 | -6.2 | - | - | - | - | - | - | - |
P/S |
0.2 | 0.2 | 1.0 | 0.6 | 8.1 | 17.8 | 9.6 | 2.2 | - | - | - | - | - | - | - |
EPS |
-1.9 | -3.9 | -3.7 | -13.9 | -4.0 | -2.0 | -0.7 | -2.8 | -7.9 | -32.5 | - | - | - | - | - |
EV (Enterprise Value) |
290 M | 299 M | 646 M | 534 M | 2.5 B | 3.3 B | 1.99 B | 393 M | 288 M | 281 M | 244 M | - | - | - | - |
EBITDA per Share |
-1.44 | -3.51 | -2.99 | -12.6 | -2.88 | -1.69 | -0.537 | -1.97 | - | - | - | - | - | - | - |
EV/EBITDA |
-3.8 | -1.8 | -5.9 | -1.3 | -26.9 | -69.2 | -149.4 | -9.0 | - | - | - | - | - | - | - |
PEG |
-0.01 | -0.0 | -0.02 | - | - | 0.33 | -1.58 | 0.05 | - | - | - | - | - | - | - |
P/B |
-7.1 | 0.6 | 2.2 | 0.8 | 3.1 | 21.2 | 14.1 | 6.4 | - | - | - | - | - | - | - |
P/CF |
5.0 | -4.8 | -1615.3 | -3.3 | -56.1 | -437.9 | 4612.9 | -12.6 | - | - | - | - | - | - | - |
ROE % |
1598.03 | -270.03 | -100.15 | -219.87 | -18.61 | -35.26 | -11.97 | -102.05 | - | - | - | - | - | - | - |
ROA % |
-36.41 | -48.13 | -23.51 | -67.31 | -10.17 | -13.12 | -7.64 | -34.50 | - | - | - | - | - | - | - |
ROCE % |
1564.47 | -279.31 | -100.65 | -216.34 | -17.75 | -34.30 | -11.87 | -40.18 | - | - | - | - | - | - | - |
Current Ratio |
1.0 | 1.2 | 1.3 | 1.4 | 2.2 | 1.6 | 2.5 | 2.4 | - | - | - | - | - | - | - |
DSO |
145.5 | 146.8 | 139.4 | 138.6 | 131.4 | 158.9 | 148.1 | 146.7 | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | 3.4 | 8.0 | - | - | - | - | - | - | - |
Operating Cycle |
145.4 | 146.8 | 139.4 | 138.6 | 131.4 | 158.9 | 148.1 | 146.7 | - | - | - | - | - | - | - |
Cash Conversion Cycle |
145.4 | 146.8 | 139.4 | 138.6 | 131.4 | 158.9 | 144.6 | 138.7 | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Cardlytics
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.25 | -1.36 | -0.18 | -0.26 | - | -2.9 | -0.09 | -0.56 | - | -0.63 | -0.67 | 0.41 | - | 0.19 | -3.75 | 0.98 | - | -1.35 | -1.43 | -0.85 | - | -0.56 | -0.73 | -1.24 | - | -0.33 | -0.29 | -0.28 | - | -0.4 | -0.64 | -1.54 | - | -0.8 | -1.69 | -4.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
-0.07 | -1.17 | -0.12 | -0.15 | - | -2.83 | -0.19 | -0.38 | - | -0.39 | -0.49 | 0.56 | - | 0.67 | -3.33 | 1.35 | - | -0.59 | -1.03 | -0.65 | - | -0.38 | -0.67 | -1.03 | - | -0.15 | -0.15 | -0.25 | - | -0.3 | -0.49 | -0.68 | - | -0.07 | -1.18 | -2.38 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
1620.30 | 1300.08 | -246.87 | -243.25 | -222.52 | -233.16 | -34.81 | -26.92 | -14.73 | -13.66 | -25.40 | -10.81 | -16.66 | -23.13 | -30.83 | -11.79 | -16.43 | -26.20 | -34.88 | -49.43 | -46.09 | -51.50 | -46.27 | -35.54 | -14.36 | -30.46 | -50.17 | -84.21 | -79.80 | -78.61 | -62.20 | -31.12 | 7.47 | 1.19 | 0.31 | 5.97 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-32.69 | -67.34 | -43.32 | -45.01 | -41.41 | -45.19 | -12.55 | -9.77 | -5.50 | -4.91 | 1.55 | 1.62 | -0.37 | -4.20 | -4.79 | -7.22 | -9.91 | -13.54 | -20.70 | -24.74 | -22.31 | -25.76 | -25.03 | -17.05 | -9.17 | -14.61 | -19.65 | -29.79 | -26.97 | -29.43 | -24.63 | -28.51 | -15.47 | -2.46 | -0.64 | -12.37 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
1626.68 | 1206.85 | -264.41 | -254.09 | -232.12 | -241.29 | -38.46 | -25.67 | -14.20 | -12.22 | -24.74 | -9.42 | -14.69 | -20.47 | -28.43 | -9.73 | -14.74 | -25.01 | -34.36 | -48.52 | -45.54 | -48.70 | -40.71 | -28.26 | -8.12 | -13.75 | -18.16 | -22.26 | -19.58 | -16.93 | -7.44 | 5.24 | 11.63 | 2.65 | 3.86 | 5.11 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
1.0 | 1.0 | 1.2 | 1.2 | 1.2 | 1.2 | 1.6 | 1.5 | 1.3 | 1.6 | 1.6 | 1.5 | 1.4 | 2.2 | - | 2.4 | 2.2 | 2.3 | 2.4 | 3.7 | 1.6 | 1.6 | 3.5 | 1.6 | 2.8 | 2.8 | 2.8 | 2.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
197.5 | 156.7 | 136.5 | 146.9 | - | 141.7 | 136.2 | 152.4 | - | 115.8 | 113.6 | 148.4 | - | 61.0 | 58.4 | 139.4 | - | 110.5 | 115.4 | 134.2 | - | 116.7 | 190.5 | 100.7 | - | 131.7 | 152.5 | 176.9 | - | 153.4 | 149.1 | 148.5 | - | 140.5 | 134.5 | 82.1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | 156.7 | 136.5 | 146.9 | - | 141.7 | 136.2 | 152.4 | - | 115.8 | 113.6 | 148.4 | - | 61.0 | 58.4 | 139.4 | - | 110.5 | 115.4 | 134.2 | - | 116.7 | 190.5 | 100.7 | - | 131.7 | 152.5 | 176.9 | - | 153.4 | 149.1 | 148.5 | - | 140.5 | 134.5 | 82.1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | 156.7 | 136.5 | 146.9 | - | 141.7 | 136.2 | 152.4 | - | 115.8 | 113.6 | 148.4 | - | 61.0 | 58.4 | 139.4 | - | 110.5 | 115.4 | 134.2 | - | 116.7 | 190.5 | 100.7 | - | 131.7 | 152.5 | 176.9 | - | 153.4 | 149.1 | 148.5 | - | 140.5 | 134.5 | 82.1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Multiples are an important financial analysis tool for the company Cardlytics, allowing investors and analysts to quickly assess the company’s value and investment attractiveness based on the ratio of market indicators to the company’s financial performance. Essentially, multiples express how the market values the company relative to its earnings, revenue, equity, or other key metrics.
Advantages of Using Financial Ratios- Simplified Data Analysis
Financial ratios transform large volumes of accounting data into compact and easily interpretable indicators, significantly simplifying the assessment of the company’s condition. - Comparability Between Companies
Multiples standardize financial metrics, enabling objective comparison of companies of different sizes, industries, and market capitalizations. - Identification of Trends and Issues
Regular analysis of ratios helps track the dynamics of financial health, identify strengths and weaknesses of the business, as well as potential risks. - Decision Support
Financial multiples serve as an important tool for investors, creditors, and company management in making investment, credit, and managerial decisions. - Accelerated Assessment of Investment Attractiveness
Ratios allow quick determination of key performance, liquidity, and financial stability indicators, facilitating prompt evaluation of companies’ attractiveness for investments.
Using multiples enables comparison between companies, even if they differ in size or industry, as they standardize financial data into ratios convenient for analysis. This is especially useful for evaluating companies where direct analysis of financial statements may be complex or require in-depth knowledge.
Argentina
China
USA
Russia
Niderland
Canada
Israel
Luxembourg
